According to Embla Medical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.19. At the end of 2024 the company had a P/S ratio of 2.44.
Year | P/S ratio | Change |
---|---|---|
2024 | 2.44 | 12.03% |
2023 | 2.17 | -23.03% |
2022 | 2.83 | -25.33% |
2021 | 3.78 | -29.54% |
2020 | 5.37 | 11.36% |
2019 | 4.82 | 46.25% |
2018 | 3.30 | 2.09% |
2017 | 3.23 | 7.99% |
2016 | 2.99 | -6.26% |
2015 | 3.19 | 27.28% |
2014 | 2.51 | 24.59% |
2013 | 2.01 | 33.77% |
2012 | 1.50 | -9.86% |
2011 | 1.67 |